Old Web
English
Sign In
Acemap
>
Paper
>
Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor.
Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor.
2019
C. Hénon
Jean-Yves Blay
Christophe Massard
O. Mir
Rastislav Bahleda
S. Dumont
Sophie Postel-Vinay
J. Adam
Jean-Charles Soria
A. Le Cesne
Keywords:
Pathology
Medicine
Pembrolizumab
SMARCA4
long lasting
Correction
Source
Cite
Save
Machine Reading By IdeaReader
9
References
29
Citations
NaN
KQI
[]